Salarius Pharmaceuticals Faces Delisting Notice
Ticker: DCOY · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1615219
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Salarius Pharma got a delisting warning - stock might be in trouble.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on April 25, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Flex Pharma, Inc., is based in Houston, Texas, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates potential issues with Salarius Pharmaceuticals' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Numbers
- 001-36812 — SEC File Number (Identifies the company's filing history with the SEC.)
- 46-5087339 — IRS Employer Identification Number (Unique tax identification number for the company.)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- Flex Pharma, Inc. (company) — Former company name
- April 23, 2025 (date) — Earliest event reported
- April 25, 2025 (date) — Date of report
- 2450 Holcombe Blvd. Suite X Houston, TX 77021 (address) — Principal executive offices
FAQ
What specific listing rule or standard has Salarius Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that Salarius Pharmaceuticals has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported in this 8-K filing is April 23, 2025.
When was Salarius Pharmaceuticals, Inc. formerly known as?
Salarius Pharmaceuticals, Inc. was formerly known as Flex Pharma, Inc.
What is the principal executive office address for Salarius Pharmaceuticals, Inc.?
The principal executive office address for Salarius Pharmaceuticals, Inc. is 2450 Holcombe Blvd. Suite X Houston, TX 77021.
What is the SIC code for Salarius Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Salarius Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).